Condensed Consolidated Interim Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 56,559	$ 64,365
Accounts receivable, net	28,771	18,223
Prepaid expenses	3,634	6,030
Other current assets	1,287	1,060
Total current assets	90,251	89,678
Property and equipment, net	16,093	13,051
Other assets	3,783	3,356
Total assets	110,127	106,085
Current liabilities:
Accounts payable	879	2,528
Accrued expenses and other current liabilities	8,963	5,578
Total current liabilities	9,842	8,106
Other liabilities	479	538
Total liabilities	10,321	8,644
Stockholders' Equity:
Additional paid-in capital	240,501	226,717
Accumulated deficit	(180,896)	(171,209)
Accumulated other comprehensive loss	(582)	(325)
Total stockholders' equity attributable to Enfusion, Inc.	59,136	55,296
Non-controlling interests	40,670	42,145
Total stockholders' equity	99,806	97,441
Total liabilities and stockholders' equity	110,127	106,085
Common Class A
Stockholders' Equity:
Common stock	67	66
Common Class B
Stockholders' Equity:
Common stock	$ 46	$ 47